
浏览全部资源
扫码关注微信
1.400038 重庆,陆军军医大学(第三军医大学)药学与检验医学系药物研究所
2.264005 山东 烟台,烟台大学分子药理和药物评价教育部重点实验室
[李晓辉,E-mail: lpsh008@aliyun.com LI Xiaohui, E-mail: lpsh008@aliyun.com
收稿:2019-10-22,
修回:2019-12-09,
纸质出版:2020-02-28
移动端阅览
李佳行, 杨胜乾, 刘娟娟, 等. 连翘苷对脂多糖诱导肝脏星状细胞活化的抑制作用[J]. 第三军医大学学报, 2020,42(4):342-349.
Jiahang LI, Shengqian YANG, Juanjuan LIU, et al. Inhibitory effect of phillyrin on lipopolysaccharide-induced activation of rat hepatic stellate cells
李佳行, 杨胜乾, 刘娟娟, 等. 连翘苷对脂多糖诱导肝脏星状细胞活化的抑制作用[J]. 第三军医大学学报, 2020,42(4):342-349. DOI: 10.16016/j.1000-5404.201910149.
Jiahang LI, Shengqian YANG, Juanjuan LIU, et al. Inhibitory effect of phillyrin on lipopolysaccharide-induced activation of rat hepatic stellate cells
目的
2
探讨连翘苷对脂多糖诱导肝脏星状细胞活化的抑制作用及其机制。
方法
2
体外培养大鼠肝星状细胞HSC-T6,实验分4组:空白对照组、脂多糖(1 μg/mL)处理组、1 μmol/L连翘苷加脂多糖处理组和10 μmol/L连翘苷加脂多糖处理组。采用MTT法检测HSC-T6细胞的增殖;Transwell实验分析细胞的迁移;流式细胞仪检测细胞内的ROS水平;ELISA法检测细胞上清中促炎细胞因子TNF-α、IL-6、IL-1β的浓度;Western blot分析细胞内α-SMA、NF-κB p65蛋白表达或蛋白磷酸化水平。
结果
2
浓度为1~100 μmol/L连翘苷对HSC-T6细胞的增殖无明显影响。脂多糖可明显促进HSC-T6细胞增殖及迁移,1 μmol/L和10 μmol/L连翘苷均可显著抑制脂多糖诱导的细胞增殖及迁移,分别降低16.13%、17.14%,48.99%、58.86%。脂多糖处理HSC-T6细胞能明显增加细胞内α-SMA蛋白的表达,而10 μmol/L连翘苷处理后,细胞内α-SMA的表达量减少27.33%。1 μmol/L和10 μmol/L连翘苷对脂多糖诱导细胞内ROS含量(30.03%、51.26%)、促炎细胞因子TNF-α、IL-6、IL-1β(25.16%、39.51%,36.57%、43.75%,58.99%、73.01%)的分泌和NF-κB p65蛋白的磷酸化水平(13.90%、24.96%)也具有显著抑制作用。相关性分析表明:连翘苷处理肝星状细胞后,其降低NF-κB p65磷酸化蛋白表达和对ROS、炎症因子(IL-1β、TNF-α)的作用与其抑制肝星状细胞活化标志物α-SMA蛋白表达的作用呈正相关。
结论
2
天然产物连翘苷能够显著抑制脂多糖诱导肝星状细胞的活化,其机制可能与其下调NF-κB信号途径介导的炎症反应有关。
Objective
2
To investigate the inhibitory effect of phillyrin (PHI) on lipopolysaccharide (LPS)-induced hepatic stellate cell (HSC) activation and explore the possible mechanisms.
Methods
2
Cultured rat hepatic stellate cells (HSC-T6) were divided into blank control group
LPS (1 μg/mL) group
LPS (1 μg/mL) + PHI (1 μg/mL) group
and LPS (1 μg/mL) + PHI (10 μg/mL) group. We assessed the changes in the proliferation and migration of the cells (HSC-T6) after the treatments using MTT assay and Transwell migration assay
respectively. The intracellular reactive oxygen species (ROS) level in the cells was determined with flow cytometry
and the concentrations of proinflammatory cytokines in the supernatant were tested using enzyme-linked immunosorbant assay (ELISA). The expression levels of α-SMA and phosphorylated nuclear factor-κB (NF-κB) p65 in the cells were analyzed with Western blotting.
Results
2
PHI from the concentration of 1 to 100 μmol/L did not significantly affect the proliferation of HSC-T6 cells. LPS stimaulation significantly promoted the proliferation and migration of the cells
and such effects were obviously suppressed by PHI treatment at both 1 (16.13% and 17.14%) and 10 μmol/L(48.99% and 58.86%). PHI at 10 μmol/L significantly reduced the expression of α-SMA (27.33%) in HSC-T6 cells exposed to LPS; at both 1 and 10 μmol/L
PHI strongly suppressed LPS-induced elevation of intracellular ROS level(30.03% and 51.26%)
lowered the levels of proinflammatory cytokines TNF-α(23.16% and 39.51%)
IL-6(36.57% and 43.75%) and IL-1β(58.99% and 73.01%) and decreased the expression of phosphorylated NF-κB p65(13.90% and 24.96%) in LPS-stimulated cells. The decreased expression level of phosphorylated NF-κB p65 protein in HSC-T6 cells was positively correlated with intracellular ROS level
concentrations of TNF-α and IL-1β
and the expression level of HSC activation marker α-SMA protein.
Conclusion
2
PHI can inhibit HSC activation induced by LPS possibly by down-regulating inflammatory responses mediated by NF-κB signaling pathway.
PAROLA M, PINZANI M. Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues[J]. Mol Aspects Med, 2019, 65: 37-55. DOI: 10.1016/j.mam.2018.09.002.
HOWELL J, PEDRANA A, COWIE B C, et al . Aiming for the elimination of viral hepatitis in Australia, New Zealand, and the Pacific Islands and Territories: where are we now and barriers to meeting world h ealth organization targets by 2030[J ] . J Gastroenterol Hepatol, 2019, 34(1): 40-48. DOI: 10.1111/jgh.14457.
HIGASHI T, FRIEDMAN S L, HOSHIDA Y. Hepatic stellate cells as key target in liver fibrosis[J]. Adv Drug Deliv Rev, 2017, 121: 27-42. DOI: 10.1016/j.addr.2017.05.007.
CHEN Y H, WU Z F, YUAN B Y, et al . MicroRNA-146a-5p attenuates irradiation-induced and LPS-induced hepatic stellate cell activation and hepatocyte apoptosis through inhibition of TLR4 pathway[J ] . Cell Death Dis, 2018, 9(2): 22. DOI: 10.1038/s41419-017-0038-z.
SHI H T, DONG L, DANG X Y, et al . Effect of chlorogenic acid on LPS-induced proinflammatory signaling in hepatic stellate cells[J ] . Inflamm Res, 2013, 62(6): 581-587. DOI: 10.1007/s00011-013-0610-7.
QU H H, ZHANG Y M, WANG Y, et al . Antioxidant and antibacterial activity of two compounds (forsythiaside and forsythin) isolated from Forsythia suspensa[J ] . J Pharm Pharmacol, 2008, 60(2): 261-266. DOI: 10.1211/jpp.60.2.0016.
WEI T, TIAN W L, YAN H Y, et al . Protective effects of phillyrin on H 2 O 2-induced oxidative stress and a poptosis in PC12 cells[J ] . Cell Mol Neurobiol, 2014, 34(8): 1165-1173. DOI: 10.1007/s10571-014-0091-4..
ZHONG W T, WU Y C, XIE X X, et al . Phillyrin attenuates LPS-induced pulmonary inflammation via suppression of MAPK and NF-κB activation in acute lung injury mice[J ] . Fitoterapia, 2013, 90: 132-139. DOI: 10.1016/j.fitote.2013.06.003..
PAN X L, CAO X, LI N, et al . Forsythin inhibits lipopolysaccharide-induced inflammation by suppressing JAK-STAT and p38 MAPK signalings and ROS production[J ] . Inflamm Res, 2014, 63(7): 597-608. DOI: 10.1007/s00011-014-0731-7.
王小芸, 赵怀舟, 倪艳.连翘应用源流初考[J].中医文献杂志, 2016, 34(5): 21-24.
WANG X Y, ZHAO H Z, NI Y. Preliminary historical research on application of lianqiao[J]. J Tradit Chin Med Lit, 2016, 34(5): 21-24.
ZHANG Y, MIAO H, YAN H Y, et al . Hepatoprotective effect of Forsythiae Fructus water extract against carbon tetrachloride-induced liver fibrosis in mice[J ] . J Ethnopharmacol, 2018, 218: 27-34. DOI: 10.1016/j.jep.2018.02.033.
EZHILARASAN D, SOKAL E, NAJIMI M. Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets[J].Hepatobil Pancreati Dis Int, 2018, 17(3): 192-197. DOI: 10.1016/j.hbpd.2018.04.003.
PUCHE J E, SAIMAN Y, FRIEDMAN S L. Hepatic stellate cells and liver fibrosis[J]. Compr Physiol, 2013, 3(4): 1473-1492. DOI: 10.1002/cphy.c120035.
CHEN H J, LIANG T M, LEE I J, et al . Scutellariae radix suppresses LPS-induced liver endothelial cell activation and inhibits hepatic stellate cell migration[J ] . J Ethnopharmacol, 2013, 150(3): 835-842. DOI: 10.1016/j.jep.2013.08.049.
ATZORI L, POLI G, PERRA A. Hepatic stellate cell: a star cell in the liver[J]. Int J Biochem Cell Biol, 2009, 41(8/9): 1639-1642. DOI: 10.1016/j.biocel.2009.03.001.
LAN T, LI C Z, YANG G Z, et al . Sphingosine kinase 1 promotes liver fibrosis by preventing miR-19b-3p-mediated inhibition of CCR2[J ] . Hepatology, 2018, 68(3): 1070-1086. DOI: 10.1002/hep.29885.
SÁNCHEZ-VALLE V, CHÁVEZ-TAPIA N C, URIBE M, et al . Role of oxidative stress and molecular changes in liver fibrosis: a review[J ] . Curr Med Chem, 2012, 19(28): 485 0-4860. DOI: 10.2174/092986712803341520.
ZHONG W H, QIAN K J, XIONG J B, et al . Curcumin alleviates lipopolysaccharide induced Sepsis and liver failure by suppression of oxidative stress-related inflammation via PI3K/AKT and NF-κB related signaling[J ] . Biomed Pharmacother, 2016, 83: 302-313. DOI: 10.1016/j.biopha.2016.06.036..
TSUCHIDA T, FRIEDMAN S L. Mechanisms of hepatic stellate cell activation[J]. Nat Rev Gastroenterol Hepatol, 2017, 14(7): 397-411. DOI: 10.1038/nrgastro.2017.38.
CHEN Y H, ZENG Z C, SHEN X Y, et al . MicroRNA-146a-5p negatively regulates pro-inflammatory cytokine secretion and cellactivation in lipopolysaccharide stimulated human hepatic stellate cells through inhibition of toll-like receptor 4 signaling pathways[J ] . Int J Mol Sci, 2016, 17(7): E1076. DOI: 10.3390/ijms17071076.
GAN F, LIU Q, LIU Y H, et al . Lycium barbarum polysaccharides improve CCl4-induced liver fibrosis, inflammatory response and TLRs/NF-kB signaling pathway expression in wistar rats[J ] . Life Sci, 2018, 192: 205-212. DOI: 10.1016/j.lfs.2017.11.047.
LUEDDE T, SCHWABE R F. NF-κB in the liver: linking injury, fibrosis and hepatocellular carcinoma[J]. Nat Rev Gastroenterol Hepatol, 2011, 8(2): 108-118. DOI: 10.1038/nrgastro.2010.213.
ZHANG J X, WANG X L, VIKASH V, et al . ROS and ROS-mediated cellular signaling[J ] . Oxidative Med Cell Longev, 2016, 2016: 1-18. DOI: 10.1155/2016/4350965.
LIU T, ZHANG L Y, JOO D, et al . NF-κB signaling in inflammation[J ] . Sig Transduct Target Ther, 2017, 2: 17023. DOI: 10.1038/sigtrans.2017.23.
PAIK Y H, KIM J, AOYAMA T, et al . Role of NADPH oxidases in liver fibrosis[J ] . Antioxid Redox Signal, 2014, 20(17): 2854-2872. DOI: 10.1089/ars.2013.5619.
KOYAMA Y, BRENNER D A. Liver inflammation and fibrosis[J]. J Clin Investig, 2017, 127(1): 55-64. DOI: 10.1172/jci88881.
LI X, JIN Q, WU Y L, et al . Tetrandrine regulates hepatic stellate cell activationvia TAK1 and NF-κB signaling[J ] . Int Immunopharmacol, 2016, 36: 263-270. DOI: 10.1016/j.intimp.2016.04.039.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621